Correlation Between Virax Biolabs and Diffusion Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Virax Biolabs and Diffusion Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Virax Biolabs and Diffusion Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Virax Biolabs Group and Diffusion Pharmaceuticals, you can compare the effects of market volatilities on Virax Biolabs and Diffusion Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Virax Biolabs with a short position of Diffusion Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Virax Biolabs and Diffusion Pharmaceuticals.
Diversification Opportunities for Virax Biolabs and Diffusion Pharmaceuticals
0.32 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Virax and Diffusion is 0.32. Overlapping area represents the amount of risk that can be diversified away by holding Virax Biolabs Group and Diffusion Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Diffusion Pharmaceuticals and Virax Biolabs is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Virax Biolabs Group are associated (or correlated) with Diffusion Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Diffusion Pharmaceuticals has no effect on the direction of Virax Biolabs i.e., Virax Biolabs and Diffusion Pharmaceuticals go up and down completely randomly.
Pair Corralation between Virax Biolabs and Diffusion Pharmaceuticals
Given the investment horizon of 90 days Virax Biolabs is expected to generate 4.96 times less return on investment than Diffusion Pharmaceuticals. In addition to that, Virax Biolabs is 4.74 times more volatile than Diffusion Pharmaceuticals. It trades about 0.03 of its total potential returns per unit of risk. Diffusion Pharmaceuticals is currently generating about 0.62 per unit of volatility. If you would invest 307.00 in Diffusion Pharmaceuticals on September 12, 2024 and sell it today you would earn a total of 20.00 from holding Diffusion Pharmaceuticals or generate 6.51% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 1.14% |
| Values | Daily Returns |
Virax Biolabs Group vs. Diffusion Pharmaceuticals
Performance |
| Timeline |
| Virax Biolabs Group |
| Diffusion Pharmaceuticals |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Virax Biolabs and Diffusion Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Virax Biolabs and Diffusion Pharmaceuticals
The main advantage of trading using opposite Virax Biolabs and Diffusion Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Virax Biolabs position performs unexpectedly, Diffusion Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Diffusion Pharmaceuticals will offset losses from the drop in Diffusion Pharmaceuticals' long position.| Virax Biolabs vs. Revelation Biosciences | Virax Biolabs vs. Kiora Pharmaceuticals | Virax Biolabs vs. Quoin Pharmaceuticals Ltd | Virax Biolabs vs. Neurobo Pharmaceuticals |
| Diffusion Pharmaceuticals vs. Bio Path Holdings | Diffusion Pharmaceuticals vs. Capricor Therapeutics | Diffusion Pharmaceuticals vs. NextCure | Diffusion Pharmaceuticals vs. Tonix Pharmaceuticals Holding |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Other Complementary Tools
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories |